Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×

Pharmaceutical Preparations CA, United States
Nasdaq: OREX
Orexigen Therapeutics, Inc. is a biopharmaceutical company engaged in the development of pharmaceutical product candidates for the treatment of obesity. Its two lead products are Contrave, which is a weight loss medication for the management of obesity and Empatic, which is an immediate release formulation, approved for the adjunctive treatment of partial seizures, a form of epilepsy. Orexigen Therapeutics was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA.
Similar to: United-Guardian, Inc., GW Pharmaceuticals Plc, Sanofi
St. Helier, JE, GB
NATURE GROUP is the market leader in handling Marpol and offshore waste, with more than 25 years’ collection and treatment experience.… Learn more →

Paris, FR
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’… Learn more →

Salisbury, WI, GB
GW Pharmaceuticals Plc researches and develops cannabinoid medicines. The companys principal activity is developing and manufacturing… Learn more →

Hauppauge, NY, US
United-Guardian, Inc. engages in the research, development, manufacture, and marketing of cosmetic ingredients, personal and health… Learn more →